Singh, Jagdeep K <br/><br/>
Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Feb 2013 
 - 643-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-1063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--genetics<br/>Cell Line, Tumor<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Interleukin-8--metabolism<br/>Neoplasm Grading<br/>Neoplasm Metastasis<br/>Neoplastic Stem Cells--metabolism<br/>RNA Interference<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Receptors, Interleukin-8A--antagonists & inhibitors<br/>Receptors, Interleukin-8B--antagonists & inhibitors<br/>Signal Transduction<br/>Spheroids, Cellular<br/>Tumor Cells, Cultured